NO154015C - Analogifremgangsmaate for fremstilling av et krystallinsk, antibiotisk virksomt cefalosporinderivat. - Google Patents

Analogifremgangsmaate for fremstilling av et krystallinsk, antibiotisk virksomt cefalosporinderivat.

Info

Publication number
NO154015C
NO154015C NO772960A NO772960A NO154015C NO 154015 C NO154015 C NO 154015C NO 772960 A NO772960 A NO 772960A NO 772960 A NO772960 A NO 772960A NO 154015 C NO154015 C NO 154015C
Authority
NO
Norway
Prior art keywords
crystallic
preparation
cephalosporin derivative
antibiotic effective
analogy procedure
Prior art date
Application number
NO772960A
Other languages
English (en)
Norwegian (no)
Other versions
NO154015B (no
NO772960L (no
Inventor
Kenzo Naito
Kazuo Tsukamura
Haruo Sinbo
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO772960L publication Critical patent/NO772960L/no
Publication of NO154015B publication Critical patent/NO154015B/no
Publication of NO154015C publication Critical patent/NO154015C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO772960A 1976-08-31 1977-08-26 Analogifremgangsmaate for fremstilling av et krystallinsk, antibiotisk virksomt cefalosporinderivat. NO154015C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51104583A JPS603314B2 (ja) 1976-08-31 1976-08-31 セフアロスポリン誘導体およびその製造法

Publications (3)

Publication Number Publication Date
NO772960L NO772960L (no) 1978-03-01
NO154015B NO154015B (no) 1986-03-24
NO154015C true NO154015C (no) 1986-07-02

Family

ID=14384446

Family Applications (1)

Application Number Title Priority Date Filing Date
NO772960A NO154015C (no) 1976-08-31 1977-08-26 Analogifremgangsmaate for fremstilling av et krystallinsk, antibiotisk virksomt cefalosporinderivat.

Country Status (15)

Country Link
US (1) US4146710A (fr)
JP (1) JPS603314B2 (fr)
BE (1) BE858296A (fr)
BG (1) BG60439B2 (fr)
CA (1) CA1102310A (fr)
CH (1) CH630088A5 (fr)
DE (1) DE2738711C2 (fr)
DK (1) DK151340C (fr)
FR (1) FR2364922A1 (fr)
GB (1) GB1589841A (fr)
HK (1) HK27784A (fr)
MY (1) MY8500266A (fr)
NL (1) NL189355C (fr)
NO (1) NO154015C (fr)
SE (1) SE426069B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575803A (en) * 1976-03-09 1980-10-01 Fujisawa Pharmaceutical Co 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof
US4189479A (en) * 1977-12-22 1980-02-19 Takeda Chemical Industries, Ltd. Cephalosporin esters
US4180658A (en) * 1978-02-24 1979-12-25 Bristol-Myers Company 7[-2-Alkoxyamino(acetamido)]cephalosporin derivatives
JPS5579393A (en) * 1978-12-11 1980-06-14 Takeda Chem Ind Ltd Cephalosporin derivative and its preparation
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
JPS58189186A (ja) * 1982-04-30 1983-11-04 Takeda Chem Ind Ltd セフアロスポリン誘導体
JPS63266177A (ja) * 1987-04-22 1988-11-02 Toyota Autom Loom Works Ltd 揺動斜板型圧縮機におけるコンロツドの連結方法
JPH06122630A (ja) * 1992-10-12 1994-05-06 Taiyo Yakuhin Kogyo Kk 安定な塩酸セフォチアム製剤
GB9503717D0 (en) * 1995-02-24 1995-04-12 Smithkline Beecham Plc Novel compounds
CN103601737B (zh) * 2013-12-04 2016-02-03 哈药集团制药总厂 一种盐酸头孢替安的制备方法
CN104926835B (zh) * 2015-06-24 2017-10-03 山东罗欣药业集团股份有限公司 一种盐酸头孢替安化合物、其制备方法及其药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ176206A (en) * 1973-12-25 1978-03-06 Takeda Chemical Industries Ltd Cephalosporins
JPS5119765A (en) * 1974-08-09 1976-02-17 Takeda Chemical Industries Ltd Aminochiazoorujudotaino seizoho

Also Published As

Publication number Publication date
SE426069B (sv) 1982-12-06
JPS5329913A (en) 1978-03-20
BG60439B2 (bg) 1995-03-31
DK385777A (da) 1978-03-01
FR2364922A1 (fr) 1978-04-14
CA1102310A (fr) 1981-06-02
JPS603314B2 (ja) 1985-01-26
NL189355B (nl) 1992-10-16
NL189355C (nl) 1993-03-16
NO154015B (no) 1986-03-24
MY8500266A (en) 1985-12-31
DE2738711A1 (de) 1978-03-02
BE858296A (fr) 1978-02-28
FR2364922B1 (fr) 1981-07-31
SE7709745L (sv) 1978-03-01
NL7709614A (nl) 1978-03-02
DK151340B (da) 1987-11-23
DK151340C (da) 1988-04-25
HK27784A (en) 1984-03-30
GB1589841A (en) 1981-05-20
NO772960L (no) 1978-03-01
US4146710A (en) 1979-03-27
CH630088A5 (de) 1982-05-28
DE2738711C2 (de) 1985-07-11

Similar Documents

Publication Publication Date Title
NO813252L (no) Fremgangsmaate for fremstilling av antibakterielle cefalosporinderivater.
SE431753B (sv) Analogifprfarande for framstellning av 2-piperazinyl-6,7-dimetoxikinazoliner
NO143149C (no) Fremgangsmaate for fremstilling av forekspanderte, videre ekspanderbare kuler
NO159531C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
SE426136B (sv) Forfarande for framstellning av ett pulverformigt, fririnnande monoglyceridadditiv
SE7706878L (sv) Forfarande for framstellning av antibakteriella foreningar
SE432595B (sv) Analogiforfarande for framstellning av piperidyl-indolderivat
SE421318B (sv) Forfarande for framstellning av antracyklinglykosidor
NO842214L (no) Fremgangsmaate for fremstilling av antibakterielle cefalosporinderivater.
NO150884C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater
NO162561C (no) Fremgangsmaate for fremstilling av oksazolinforbindelser egnet for fremstilling av antibakterielt virksomme 1-oksa-detiacefalosporiner.
NO148959C (no) Fremgangsmaate ved fremstilling av tumor-motvirkende antracyklinglykosidantibiotika, betegnet ma 144
NO154015C (no) Analogifremgangsmaate for fremstilling av et krystallinsk, antibiotisk virksomt cefalosporinderivat.
DK479976A (da) Fremgangsmade til fremstilling af antibiotiske cephalosporinderivater
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
NL7902316A (nl) Cefalosporine-derivaten.
NO147716C (no) Analogifremgangsmaate for fremstilling av antibakterielle erytromycylaminderivater.
NO150087C (no) Fremgangsmaate for fremstilling av cellulosemasse
SE431336B (sv) Analogiforfarande for framstellning av substituerade 8-azapurinderivat
NO824305L (no) Fremgangsmaate for fremstilling av antibakterielle pencillinderivater.
NO157864C (no) Analogifremgangsaate for fremstilling av nye, terapeutisk virksomme diklorerte 16alfa-methylpregnanderivater.
NO147423C (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater.
ES488848A0 (es) Un procedimiento para la preparacion de un antibiotico de cefalosporina.
NO154057C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isopropylamino-pyrimidin-halogenderivater.
NO154965C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolderivater.